Eye cancer study dispels the theory of nerve activity

Article

Researchers have identified a cell that causes eye cancer, suggesting for the first time that deliberate genetic manipulations may encourage the brain to heal itself.

Researchers have identified a cell that causes eye cancer, suggesting for the first time that deliberate genetic manipulations may encourage the brain to heal itself. The study, published in Cell, has dispelled a long-standing theory about nerve growth and development.

Michael Dyer and colleagues at St Jude Children's Research Hospital, US, found that reducing the activity of the Rb genes in mice retina enables fully differentiated horizontal neurons to multiply while retaining the features of normal horizontal neurons. This demonstrates that retinoblastoma can arise from fully matured horizontal interneurons in the retina and thereby disproves the idea that fully developed nerves cannot multiply like young cells.

Based on these findings, the researchers believe that it may be possible for scientists to induce fully developed neurons to help the brain to heal itself by controlling gene activity in the neurons. This will encourage them to multiply and replace the neurons that were lost as a result of neurodegenerative diseases such as Alzheimer's.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.